Mark Lawler/X
Jun 11, 2025, 14:40
Delighted to Announce Our Ground-Breaking €10M PEACEPLUS Digital ONEHEALTH Programme – Mark Lawler
Mark Lawler, Chair in Translational Cancer Genomics and the Associate Director of Postgraduate Studies at Queen’s University Belfast, shared a post on X:
“Delighted to announce our ground-breaking €10M PEACEPLUS Digital ONEHEALTH Programme, Queen’s University Belfast, led by Catalyst and with partners.”
Then he shared another post on X, adding:
“ONEHEALTH will deploy the latest AI and digital innovations and platforms to solve the most relevant human, animal and environmental issues in our region, delivering the health dividend of peace and the economic dividend of health”
More posts featuring Mark Lawler on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 14, 2025, 03:06
Aug 14, 2025, 03:04
Aug 13, 2025, 21:09
Aug 13, 2025, 20:52
Aug 13, 2025, 20:36